Highland Capital Management (Texas)’s Pfizer PFE Stock Holding History

Highland Capital Management (Texas)’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-6,324	Closed	-$217K	–	359
2017 Q4	$217K	Hold	6,324	–	–	0.01%	286
2017 Q3	$214K	Sell	6,324 -99,076	-94%	-$3.18M	0.01%	284
2017 Q2	$3.36M	Buy	+105,400	New	+$3.32M	0.14%	111
2016 Q3	–	Sell	-289,007	Closed	-$9.65M	–	348
2016 Q2	$9.65M	Sell	289,007 -403,933	-58%	-$12.9M	0.4%	67
2016 Q1	$19.5M	Sell	692,940 -340,785	-33%	-$9.73M	0.86%	30
2015 Q4	$31.7M	Buy	+1,033,725	New	+$32.5M	1.01%	20

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Highland Capital Management (Texas)'s PFE Position: Q1 2018 in Review

Highland Capital Management (Texas) sold out of Pfizer (PFE) in Q1 2018, closing a stake of 6,324 shares — an estimated $217K sold.

Highland Capital Management (Texas) first reported a position in PFE in Q4 2015 and held it in 6 quarters. The position peaked at $31.7M in Q4 2015. 2,229 funds tracked by Wall St. Rank hold PFE as of Q1 2018.

Highland Capital Management (Texas) reported no remaining Pfizer position as of Q1 2018 after selling out during the quarter.
Highland Capital Management (Texas) sold 6,324 Pfizer shares in Q1 2018, an estimated $217K.
Highland Capital Management (Texas) first reported a position in Pfizer in Q4 2015 and held it in 6 quarters.
Highland Capital Management (Texas)'s Pfizer position peaked at $31.7M in Q4 2015.
2,229 funds tracked by Wall St. Rank held Pfizer as of Q1 2018.

Based on Highland Capital Management (Texas)'s 13F filing for Q1 2018, filed 15 May 2018.